Aurobindo Pharma gets USFDA nod for anti-depressant drug

Posted on: Wed, 04 Mar 2009 21:41:00 EST


Symbols: AUBPF
Mumbai, Mar 04, 2009 (Asia Pulse Data Source via COMTEX) --
AUBPF | Quote | Chart | News | PowerRating -- Drug-maker Aurobindo Pharma today said it has received tentative approval from the US drug regulator for anti-depressant tablets Escitalopram Oxalate.

In a filing with the Bombay Stock Exchange, Aurobindo Pharma said it got tentative approval from the US Food and Drug Administration (USFDA) for Escitalopram Oxalate tablets.

Escitalopram Oxalate tablets are the generic version of Forest Laboratories' Lexapro used in treating patients suffering from depression and mood disorders, it added.

Escitalopram Oxalate tablets will be available in 5 mg, 10 mg and 20 mg.

Aurobindo now has 92 approved Abbreviated New Drug Application (ANDA) from the USFDA.

Shares of the company were trading at Rs 160.40, up 2.79 per cent on the BSE.

For full details on (AUBPF) AUBPF. (AUBPF) has Short Term PowerRatings at TradingMarkets. Details on (AUBPF) Short Term PowerRatings is available at This Link.

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday February 11 04:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.